Drugs / Trappa ethanolamine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05797623 | Apr 2023 → May 2024 | aplastic anemia | Jiangsu HengRui Medicine Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trappa ethanolamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05797623 ↗ |